She has expertise in the diagnosis and treatment of individuals with atypical dementias including Parkinson’s plus syndromes and frontotemporal degeneration spectrum disorders (FTD). Her research focuses on multimodal imaging biomarkers. She is the site PI for the national FTD Consortium, supporting the MBWC’s qualifications as a premier institute for atypical dementias. As the leader of the Outreach, Recruitment, and Education Core of the UW Alzheimer’s Disease Research Center (ADRC), she aims to raise awareness of Alzheimer’s disease and related disorders, and associated research opportunities.